title: [Annual trends (2008-2011) in early childhood vaccination coverage for the French population: the Vaccinoscopie(®) study].
abstract: Assessing vaccination coverage (VC) is a critical part of adherence to immunization guidelines and beyond vaccine effectiveness can fill possible gaps and optimize VC. The aim of this study was to measure annual VC trends (2008-2011) among children 0-6years of age.
  
  
  METHODS
  An Internet survey was conducted using a self-administrated questionnaire to a representative sample (quota method) of mothers reporting their child's immunization record.
  
  
  RESULTS
  Diphtheria-tetanus-poliomyelitis-pertussis VC (complete schedule) was 96.0% at 6 years of age in 2010. Hepatitis B VC (≥1 dose) in the 6- to 11-month-old population increased from 54.6% in 2008 to 80.5% in 2011, but only 34.7% of 6-year-old had received a complete schedule in 2010. Pneumococcal conjugate vaccine VC (complete schedule) increased to 92.7% in the 24- to 35-month-old population. Measles-mumps-rubella (MMR) VC (2 injections) increased in 24- to 35-month-olds from 60.3% in 2008 to 81.0% in 2011. In 2011, 64.2% of 24- to 35-month-olds had received a second dose of MMR vaccine before 25 months vs. 45.4% in 2008. BCG VC in 12- to 35-month-olds was 73.2% in Île-de-France, where vaccination is recommended in all children vs. 15.5% elsewhere (vaccination only recommended in high-risk children).
  
  
  CONCLUSIONS
  This study shows a significant improvement of VC in young French children. However, outreach efforts should continue to be made, especially to adolescent and adult populations, in whom VC is very low.
authors.affiliation: EA 2694, clinique de pédiatrie, CHU de Lille, université Lille Nord de France, 2, avenue Oscar-Lambret, 59037 Lille, France. alain.martinot@chru-lille.fr
authors.forename: A
authors.initials: A
authors.lastname: Martinot
authors.forename: R
authors.initials: R
authors.lastname: Cohen
authors.forename: F
authors.initials: F
authors.lastname: Denis
authors.forename: J
authors.initials: J
authors.lastname: Gaudelus
authors.forename: T
authors.initials: T
authors.lastname: Lery
authors.forename: M
authors.initials: M
authors.lastname: Le Danvic
authors.forename: J-P
authors.initials: JP
authors.lastname: Stahl
mesh_terms: D000367:Age Factors; D001500:BCG Vaccine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage; D005602:France; D019983:Guideline Adherence / Q000706:statistics & numerical data; D018073:Haemophilus Vaccines / Q000008:administration & dosage; D006306:Health Surveys; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary; D007223:Infant; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D023321:Poliovirus Vaccines / Q000008:administration & dosage; D057566:Self Report; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D001500:BCG Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; D017325:Hepatitis B Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D022242:Pneumococcal Vaccines; D023321:Poliovirus Vaccines